Equities in Focus – Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), CME Group Inc (NASDAQ:CME), Intermolecular Inc (NASDAQ:IMI)
Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), a development-stage biopharmaceutical company, Monday released encouraging results from a Phase 2 extension study of sialic acid extended-release...